New research suggests that abruptly stopping beta-blocker treatment after a myocardial infarction (heart attack) could be especially perilous for individuals with pre-existing hypertension. the 2024 study, published by the American Society of Stress Sciences (ASSS), initially pointed to a correlation between beta-blocker cessation and increased risk of mortality and cardiovascular events. Follow-up analysis indicates that inadequate blood pressure and heart rate management might potentially be a key factor in this elevated risk.

Blood Pressure Control is Critical

The study underscores the importance of carefully managing blood pressure and heart rate when discontinuing beta-blockers, especially in patients with hypertension. Doctors should closely monitor these vital signs and adjust treatment plans accordingly to minimize potential risks.

“Inadequate blood pressure and heart rate management may be a key factor”

Beta-blockers are commonly prescribed after a heart attack to reduce the heart’s workload and prevent future cardiac events. However, discontinuing these medications can lead to a rebound effect, causing blood pressure and heart rate to surge. For individuals already struggling with hypertension, this rebound effect can be particularly hazardous.

Individualized Treatment Strategies Recommended

Experts recommend that healthcare providers adopt individualized treatment strategies when considering beta-blocker withdrawal in post-myocardial infarction patients with hypertension. This approach should include gradual dose reduction, close monitoring of blood pressure and heart rate, and the implementation of alternative therapies to maintain cardiovascular stability.